Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOSTATA ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.5% 0.4% 1.1% 0.4% 2.7% 1.0% 9.6% 9.4%   Credit score (0-100)   98 100 84 99 59 86 26 26   Credit rating   AA AAA A AAA BBB A BB BB   Credit limit (kDKK)   987.0 814.9 386.7 970.1 0.0 208.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   13,992 13,559 13,329 14,888 11,440 10,861 0.0 0.0   EBITDA   2,632 1,263 238 2,428 -1,476 315 0.0 0.0   EBIT   2,524 1,107 65.9 2,229 -1,599 262 0.0 0.0   Pre-tax profit (PTP)   2,595.6 1,204.2 624.1 1,612.2 -1,442.3 433.8 0.0 0.0   Net earnings   2,022.6 937.1 489.9 1,260.5 -1,137.9 337.4 0.0 0.0   Pre-tax profit without non-rec. items   2,596 1,204 624 1,612 -1,442 434 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   99.5 458 286 184 60.2 7.1 0.0 0.0   Shareholders equity total   5,948 4,885 4,875 5,635 1,497 1,835 1,635 1,635   Interest-bearing liabilities   0.0 287 0.0 0.0 930 878 0.0 0.0   Balance sheet total (assets)   8,900 8,745 10,206 8,947 5,773 5,408 1,635 1,635   Net Debt   -3,797 -4,330 -7,456 -4,735 -914 -1,186 -1,635 -1,635     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   13,992 13,559 13,329 14,888 11,440 10,861 0.0 0.0   Gross profit growth   12.0% -3.1% -1.7% 11.7% -23.2% -5.1% -100.0% 0.0%   Employees   0 13 13 14 14 10 0 0   Employee growth %   0.0% 0.0% 0.0% 7.7% 0.0% -28.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   8,900 8,745 10,206 8,947 5,773 5,408 1,635 1,635   Balance sheet change%   35.3% -1.8% 16.7% -12.3% -35.5% -6.3% -69.8% 0.0%   Added value   2,631.6 1,262.9 238.1 2,428.2 -1,400.3 315.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -216 203 -344 -302 -247 -106 -7 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   18.0% 8.2% 0.5% 15.0% -14.0% 2.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   33.9% 13.8% 8.0% 23.8% -18.8% 8.7% 0.0% 0.0%   ROI %   50.1% 20.6% 13.1% 37.6% -28.3% 14.1% 0.0% 0.0%   ROE %   38.7% 17.3% 10.0% 24.0% -31.9% 20.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   66.8% 55.9% 47.8% 63.0% 25.9% 33.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -144.3% -342.8% -3,131.9% -195.0% 62.0% -376.0% 0.0% 0.0%   Gearing %   0.0% 5.9% 0.0% 0.0% 62.1% 47.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 8.2% 92.6% 0.0% 13.0% 6.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   3.5 2.7 2.1 3.8 1.6 1.9 0.0 0.0   Current Ratio   3.5 2.7 2.1 3.8 1.6 1.9 0.0 0.0   Cash and cash equivalent   3,796.5 4,616.5 7,456.3 4,735.4 1,844.7 2,064.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,699.1 453.7 -13.7 1,686.7 207.2 396.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 97 18 173 -100 32 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 97 18 173 -105 32 0 0   EBIT / employee   0 85 5 159 -114 26 0 0   Net earnings / employee   0 72 38 90 -81 34 0 0